Ingalls & Snyder LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.26M | Sell |
14,937
-56
| -0.4% | -$20K | 0.19% | 97 |
|
|
2025
Q4 | $4.91M | Sell |
14,993
-696
| -4% | -$221K | 0.18% | 92 |
|
|
2025
Q3 | $4.43M | Sell |
15,689
-119
| -0.8% | -$34.5K | 0.14% | 101 |
|
|
2025
Q2 | $4.41M | Buy |
15,808
+148
| +0.9% | +$41.9K | 0.16% | 101 |
|
|
2025
Q1 | $4.88M | Hold |
15,660
| – | – | 0.16% | 87 |
|
|
2024
Q4 | $4.08M | Buy |
15,660
+200
| +1% | +$59.3K | 0.16% | 103 |
|
|
2024
Q3 | $4.98M | Buy |
15,460
+50
| +0.3% | +$16.4K | 0.19% | 87 |
|
|
2024
Q2 | $4.82M | Sell |
15,410
-11
| -0.1% | -$3.23K | 0.21% | 84 |
|
|
2024
Q1 | $4.38M | Sell |
15,421
-325
| -2% | -$95.1K | 0.19% | 85 |
|
|
2023
Q4 | $4.54M | Hold |
15,746
| – | – | 0.21% | 82 |
|
|
2023
Q3 | $4.23M | Sell |
15,746
-15
| -0.1% | -$3.74K | 0.2% | 85 |
|
|
2023
Q2 | $3.5M | Hold |
15,761
| – | – | 0.17% | 98 |
|
|
2023
Q1 | $3.81M | Sell |
15,761
-104
| -0.7% | -$25.5K | 0.2% | 85 |
|
|
2022
Q4 | $4.17M | Sell |
15,865
-1,480
| -9% | -$397K | 0.23% | 78 |
|
|
2022
Q3 | $3.91M | Sell |
17,345
-6
| -0% | -$1.45K | 0.22% | 77 |
|
|
2022
Q2 | $4.22M | Sell |
17,351
-2
| -0% | -$490 | 0.22% | 77 |
|
|
2022
Q1 | $4.2M | Buy |
17,353
+125
| +0.7% | +$28.7K | 0.19% | 98 |
|
|
2021
Q4 | $3.88M | Sell |
17,228
-12
| -0.1% | -$2.53K | 0.17% | 106 |
|
|
2021
Q3 | $3.67M | Hold |
17,240
| – | – | 0.17% | 113 |
|
|
2021
Q2 | $4.2M | Sell |
17,240
-1,319
| -7% | -$324K | 0.19% | 98 |
|
|
2021
Q1 | $4.62M | Sell |
18,559
-516
| -3% | -$123K | 0.22% | 91 |
|
|
2020
Q4 | $4.39M | Buy |
+19,075
| New | +$4.4M | 0.22% | 88 |
|
|
2020
Q3 | – | Sell |
-12,796
| Closed | -$3.02M | – | 376 |
|
|
2020
Q2 | $3.02M | Sell |
12,796
-242
| -2% | -$55.2K | 0.17% | 103 |
|
|
2020
Q1 | $2.64M | Buy |
+13,038
| New | +$2.85M | 0.18% | 105 |
|
|
2019
Q4 | – | Sell |
-13,474
| Closed | -$2.61M | – | 409 |
|
|
2019
Q3 | $2.61M | Sell |
13,474
-1
| -0% | -$192 | 0.13% | 128 |
|
|
2019
Q2 | $2.48M | Sell |
13,475
-796
| -6% | -$143K | 0.12% | 138 |
|
|
2019
Q1 | $2.71M | Sell |
14,271
-195
| -1% | -$37.2K | 0.13% | 129 |
|
|
2018
Q4 | $2.82M | Sell |
14,466
-794
| -5% | -$155K | 0.15% | 120 |
|
|
2018
Q3 | $3.16M | Sell |
15,260
-3
| -0% | -$591 | 0.13% | 126 |
|
|
2018
Q2 | $2.82M | Sell |
15,263
-155
| -1% | -$27.4K | 0.13% | 126 |
|
|
2018
Q1 | $2.63M | Buy |
15,418
+1,066
| +7% | +$196K | 0.13% | 131 |
|
|
2017
Q4 | $2.5M | Buy |
+14,352
| New | +$2.54M | 0.11% | 134 |
|
|
2017
Q2 | – | Sell |
-14,423
| Closed | -$2.37M | – | 376 |
|
|
2017
Q1 | $2.37M | Buy |
14,423
+101
| +0.7% | +$16.8K | 0.13% | 122 |
|
|
2016
Q4 | $2.09M | Buy |
14,322
+1,684
| +13% | +$253K | 0.11% | 136 |
|
|
2016
Q3 | $2.11M | Sell |
12,638
-260
| -2% | -$44K | 0.12% | 132 |
|
|
2016
Q2 | $1.96M | Sell |
12,898
-156
| -1% | -$24.3K | 0.12% | 130 |
|
|
2016
Q1 | $1.96M | Buy |
13,054
+955
| +8% | +$142K | 0.12% | 118 |
|
|
2015
Q4 | $1.96M | Sell |
12,099
-600
| -5% | -$94.3K | 0.13% | 112 |
|
|
2015
Q3 | $1.76M | Sell |
12,699
-79
| -0.6% | -$12.5K | 0.11% | 125 |
|
|
2015
Q2 | $1.96M | Sell |
12,778
-370
| -3% | -$59.3K | 0.11% | 126 |
|
|
2015
Q1 | $2.1M | Buy |
13,148
+1,150
| +10% | +$181K | 0.12% | 122 |
|
|
2014
Q4 | $1.91M | Sell |
11,998
-504
| -4% | -$78.5K | 0.11% | 130 |
|
|
2014
Q3 | $1.76M | Sell |
12,502
-72
| -0.6% | -$9.4K | 0.09% | 136 |
|
|
2014
Q2 | $1.49M | Buy |
12,574
+166
| +1% | +$19.2K | 0.07% | 154 |
|
|
2014
Q1 | $1.53M | Sell |
12,408
-270
| -2% | -$32.7K | 0.08% | 152 |
|
|
2013
Q4 | $1.45M | Sell |
12,678
-405
| -3% | -$46.1K | 0.08% | 151 |
|
|
2013
Q3 | $1.46M | Sell |
13,083
-185
| -1% | -$20.1K | 0.09% | 142 |
|
|
2013
Q2 | $1.31M | Buy |
+13,268
| New | +$1.38M | 0.08% | 155 |
|
Other funds holding AMGN
VCM
VPM
Ingalls & Snyder LLC's AMGN Position: Q1 2026 in Review
Ingalls & Snyder LLC reduced its Amgen (AMGN) stake by 0.37% in Q1 2026, selling an estimated $20K and leaving 14,937 shares worth $5.26M. The position accounts for 0.19% of the portfolio, ranked #97.
Ingalls & Snyder LLC first reported a position in AMGN in Q2 2013 and has held it in 48 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Ingalls & Snyder LLC held 14,937 shares of Amgen worth $5.26M as of Q1 2026.
- Ingalls & Snyder LLC sold 56 Amgen shares in Q1 2026, an estimated $20K.
- Amgen made up 0.19% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #97 holding.
- Ingalls & Snyder LLC first reported a position in Amgen in Q2 2013 and has held it in 48 quarters since.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.